2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $141M | $218M | $381M | $463M | $546M |
Cost of Revenue | $108M | $161M | $233M | $285M | $330M |
Gross Profit | $33M | $57M | $148M | $178M | $216M |
Gross Profit % | 24% | 26% | 39% | 39% | 40% |
R&D Expenses | $12M | $18M | $31M | $34M | $39M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$31M | -$61M | -$76M | -$67M | -$50M |
Dep. & Amort. | $3.1M | $3.6M | $7.8M | $11M | $13M |
Def. Tax | $1.6M | -$179K | -$653K | -$154K | -$46K |
Stock Comp. | $1M | $7.4M | $19M | $22M | $29M |
Chg. in WC | $2M | -$24M | -$29M | -$14M | -$15M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $60M | $86M | $319M | $53M | $22M |
ST Investments | $0 | $30M | $254M | $215M | $218M |
Cash & ST Inv. | $60M | $117M | $319M | $269M | $240M |
Receivables | $15M | $32M | $49M | $70M | $74M |
Inventory | $2.3M | $2M | $1.6M | $2.9M | $3.9M |
Xometry reported a strong Q4 2024, with revenue increasing 16% year-over-year to $149 million, driven by 20% growth in marketplace revenue and a record addition of 3,400 active buyers.
The company achieved adjusted EBITDA profitability in Q4, with $1 million in adjusted EBITDA, a $3.9 million improvement year-over-year, and expects to remain adjusted EBITDA positive for the full year 2025.
Xometry provided guidance for Q1 2025, expecting revenue growth of 20%-21% year-over-year and marketplace growth of 24%-26%, with an adjusted EBITDA loss of approximately $1.5 million due to temporary gross margin headwinds from accelerated global sourcing investments.
The company highlighted its focus on key growth initiatives for 2025, including expanding buyer and supplier networks, driving deeper enterprise engagement, enhancing its marketplace menu with AI-driven quoting capabilities, and growing internationally, particularly in Europe and APAC.
Xometry expects overall revenue growth in 2025 to exceed 2024 levels, with marketplace revenue growing at least 20% across each quarter and incremental adjusted EBITDA margins of approximately 20%.